Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2
Authors:
- Claudia Di BlasiCBClaudia Di Blasi
- Emanuela BellafioreEBEmanuela Bellafiore
- Mustafa Am SalihMSMustafa Am Salih
- M Chiara ManziniMMM Chiara Manzini
- Steven A MooreSMSteven A Moore
- Mohammed Z SeidahmedMSMohammed Z Seidahmed
- Maowia M MukhtarMMMaowia M Mukhtar
- Zein A KarrarZKZein A Karrar
- Christopher A WalshCWChristopher A Walsh
- Kevin P CampbellKCKevin P Campbell
- Renato MantegazzaRMRenato Mantegazza
- Lucia MorandiLMLucia Morandi
Open Access
- 13 December 2011
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 534
Abstract
Congenital muscular dystrophy type 1A is caused by mutations in the LAMA2 gene that encodes the laminin α2 chain, a component of the skeletal muscle extracellular matrix protein laminin-211. The clinical spectrum of the disease is more heterogeneous than previously thought, particularly in terms of motor achievement and disease progression. We investigated clinical findings and performed molecular genetic analysis in 3 families from Saudi Arabia and 1 from Sudan in whom congenital muscular dystrophy 1A was suspected based on homozygosity mapping and laminin α2 chain deficiency. We investigated 9 affected individuals from 1 Sudanese and 3 Saudi families in whom MDC1A was suggested by clinical, neuroimaging and/or pathological findings and by homozygosity mapping at the LAMA2 locus. Morphological and immunohistochemical analysis were performed in 3 patients from the 3 Saudi families. SSCP analysis, DNA sequencing and microsatellite analysis were carried out in the 4 index cases. A previously described mutation in the LAMA2 gene, a homozygous T > C substitution at position +2 of the consensus donor splice site of exon 26, was found in the 4 index patients. Clinical evaluation of 9 patients from the 4 families revealed variable disease severity particularly as regards motor achievement and disease progression. Microsatellite analysis showed an identical mutation-associated haplotype in the 4 index cases indicating a founder effect of the mutation in all 4 families. Our data provide further evidence that the clinical spectrum of MDC1A due to a single mutation is heterogeneous, particularly in terms of motor achievement and disease progression, making it difficult to give a reliable prognosis even in patients with identical LAMA2-associated haplotype. The c.3924 + 2 T > C mutation to date has been found only in patients originating from the Middle East or Sudan; therefore laminin 2 chain deficiency in patients from those regions should initially prompt a search for this mutation.Keywords
This publication has 22 references indexed in Scilit:
- Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutationsNeuromuscular Disorders, 2010
- Molecular Prenatal Diagnosis of Muscular Dystrophies in Tunisia and Postnatal Follow-Up RoleGenetic Testing, 2008
- Genetic modifiers of muscular dystrophy: Implications for therapyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- A simplified laminin nomenclatureMatrix Biology, 2005
- PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy.Journal of Medical Genetics, 1998
- CLINICAL AND MOLECULAR PATHOLOGICAL FEATURES OF SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY IN SAUDI ARABIADevelopmental Medicine & Child Neurology, 1996
- Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophyNature Genetics, 1995
- Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletalNeuromuscular Disorders, 1995
- Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy 22–24 April 1994, The NetherlandsNeuromuscular Disorders, 1995
- Severe Autosomal Recessive Muscular Dystrophy in an Extended Sudanese KindredDevelopmental Medicine & Child Neurology, 1983